
Hyades Pharmaceuticals Private Limited
About Hyades Pharmaceuticals Private Limited
Data last updated:
Hyades Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 15 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74140HR2015PTC055774. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Babita Sinha and Subodh Kumar Sinha.
Its last annual general meeting (AGM) was held on 28 December 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Unit No – 504 A Unitech Arcadia South City 2, Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2022, the company reported a revenue of ₹8.15 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹3.31 Lakh (net margin -40.6%) and EBITDA of -₹3.28 Lakh (EBITDA margin -40.3%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 34% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hyades Pharmaceuticals Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No – 504 A Unitech Arcadia South City 2, Gurgaon, Haryana, India – 122001
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Hyades Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hyades Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Hyades Pharmaceuticals Private Limited, buy the company report.
Financials of Hyades Pharmaceuticals Private Limited
FY 2022 filings availableHyades Pharmaceuticals Private Limited reported revenue of ₹8.15 Lakh (down 28% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 34% over five years, including a 28% fall in the latest year. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -40.3% | ||||
| Net Profit Margin | -40.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hyades Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hyades Pharmaceuticals Private Limited
Hyades Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Babita Sinha | Director | 01 May 2018 | 8 Years 6 Months | Current |
| Subodh Kumar Sinha | Director | 15 Jun 2015 | 11 Years 5 Months | Current |
Auditor
Hyades Pharmaceuticals Private Limited is audited by V K JAISWAL & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V K JAISWAL & CO | FY 2019 | 022117N |
Shareholding
The shareholding of Hyades Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hyades Pharmaceuticals Private Limited, buy the company report.
Legal cases
Hyades Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Civil suit | Filed against the company by M/S Angiolife Healthcare Pvt Ltd | Pending |
To see the full case history of Hyades Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hyades Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hyades Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Hyades Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hyades Pharmaceuticals Private Limited has 7 board changes on record since 2015: 2 appointments and 5 cessations. The latest: Aditi Sinha ceased to be Director on 01 Jan 2022.
Frequently asked questions
Hyades Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 15 June 2015 (11+ years old) and is registered under CIN U74140HR2015PTC055774.
Hyades Pharmaceuticals has 2 current directors:
- Babita Sinha - Director
- Subodh Kumar Sinha - Director
The latest financial statements of Hyades Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 28 December 2022. Year-wise statements from FY 2016 are in the company report.
No. Hyades Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Hyades Pharmaceuticals is U74140HR2015PTC055774. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hyades Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Hyades Pharmaceuticals was incorporated on 15 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Haryana.
Aditi Sinha ceased to be Director on 01 Jan 2022. Babita Sinha ceased to be Additional Director on 29 Sep 2018. Pallavi Kumari ceased to be Director on 30 Jun 2018. Hyades Pharmaceuticals has 7 board changes on record in total.
The registered office of Hyades Pharmaceuticals is at Unit No – 504 A Unitech Arcadia South City 2, Gurgaon, Haryana, India – 122001.
Hyades Pharmaceuticals operates in the chemicals and materials industry, in the chemical distribution and retail segment.

